These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16809328)

  • 41. Ancestral and consensus envelope immunogens for HIV-1 subtype C.
    Kothe DL; Li Y; Decker JM; Bibollet-Ruche F; Zammit KP; Salazar MG; Chen Y; Weng Z; Weaver EA; Gao F; Haynes BF; Shaw GM; Korber BT; Hahn BH
    Virology; 2006 Sep; 352(2):438-49. PubMed ID: 16780913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.
    Cotton LA; Kuang XT; Le AQ; Carlson JM; Chan B; Chopera DR; Brumme CJ; Markle TJ; Martin E; Shahid A; Anmole G; Mwimanzi P; Nassab P; Penney KA; Rahman MA; Milloy MJ; Schechter MT; Markowitz M; Carrington M; Walker BD; Wagner T; Buchbinder S; Fuchs J; Koblin B; Mayer KH; Harrigan PR; Brockman MA; Poon AF; Brumme ZL
    PLoS Genet; 2014 Apr; 10(4):e1004295. PubMed ID: 24762668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.
    Campbell MS; Mullins JI; Hughes JP; Celum C; Wong KG; Raugi DN; Sorensen S; Stoddard JN; Zhao H; Deng W; Kahle E; Panteleeff D; Baeten JM; McCutchan FE; Albert J; Leitner T; Wald A; Corey L; Lingappa JR;
    PLoS One; 2011 Mar; 6(3):e16986. PubMed ID: 21399681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Selection of HIV escape mutants by CTL and adaptation of HIV to HLA class I].
    Takiguchi M
    Uirusu; 2009 Dec; 59(2):145-53. PubMed ID: 20218323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV evolution in response to HLA-restricted CTL selection pressures: a population-based perspective.
    Carlson JM; Brumme ZL
    Microbes Infect; 2008 Apr; 10(5):455-61. PubMed ID: 18407775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA-mediated control of HIV and HIV adaptation to HLA.
    Payne RP; Matthews PC; Prado JG; Goulder PJ
    Adv Parasitol; 2009; 68():1-20. PubMed ID: 19289188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering.
    Matthews PC; Leslie AJ; Katzourakis A; Crawford H; Payne R; Prendergast A; Power K; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung'u T; Walker BD; Allen TM; Pybus OG; Goulder PJ
    J Virol; 2009 May; 83(9):4605-15. PubMed ID: 19244334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.
    Bolesta E; Kowalczyk A; Wierzbicki A; Eppolito C; Kaneko Y; Takiguchi M; Stamatatos L; Shrikant PA; Kozbor D
    J Immunol; 2006 Jul; 177(1):177-91. PubMed ID: 16785513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of HLA class I-associated amino acid polymorphisms in the HIV-1C proteome.
    Boutwell CL; Essex M
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):165-74. PubMed ID: 17263647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen.
    Weaver EA; Lu Z; Camacho ZT; Moukdar F; Liao HX; Ma BJ; Muldoon M; Theiler J; Nabel GJ; Letvin NL; Korber BT; Hahn BH; Haynes BF; Gao F
    J Virol; 2006 Jul; 80(14):6745-56. PubMed ID: 16809280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential immune escape mutations under inferred selection pressure in HIV-1 strains circulating in Medellín, Colombia.
    Arcia D; Ochoa R; Hernández JC; Álvarez CM; Díaz FJ; Velilla PA; Acevedo-Sáenz L
    Infect Genet Evol; 2019 Apr; 69():267-278. PubMed ID: 30808498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS.
    Shearer GM; Pinto LA; Clerici M
    Immunol Today; 1999 Feb; 20(2):66-71. PubMed ID: 10098324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct.
    Kumar S; Yan J; Muthumani K; Ramanathan MP; Yoon H; Pavlakis GN; Felber BK; Sidhu M; Boyer JD; Weiner DB
    DNA Cell Biol; 2006 Jul; 25(7):383-92. PubMed ID: 16848679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
    Becker Y
    Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-Resolution Sequencing of Viral Populations during Early Simian Immunodeficiency Virus Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.
    Ita S; Hill AK; Lam EC; Dufort FJ; Yang X; Newman R; Leviyang S; Fofana IB; Johnson WE
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice.
    Bruce CB; Akrigg A; Sharpe SA; Hanke T; Wilkinson GWG; Cranage MP
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2621-2628. PubMed ID: 10573155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune responses and HIV: a little order from the chaos.
    O'Connor DH; Burton DR
    J Exp Med; 2006 Mar; 203(3):501-3. PubMed ID: 16533889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.